TSCAN THERAPEUTICS INC's ticker is and the CUSIP is 89854M101. A total of 33 filers reported holding TSCAN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,757,324 | +2.4% | 1,077,080 | 0.0% | 0.18% | +22.1% |
| Q2 2023 | $2,692,700 | +19.0% | 1,077,080 | 0.0% | 0.14% | +16.0% |
| Q1 2023 | $2,261,868 | +37.3% | 1,077,080 | 0.0% | 0.12% | +30.2% |
| Q4 2022 | $1,647,932 | -49.8% | 1,077,080 | 0.0% | 0.10% | -42.9% |
| Q3 2022 | $3,285,000 | -3.0% | 1,077,080 | 0.0% | 0.17% | -8.7% |
| Q2 2022 | $3,387,000 | +12.3% | 1,077,080 | 0.0% | 0.18% | +87.8% |
| Q1 2022 | $3,016,000 | -37.8% | 1,077,080 | 0.0% | 0.10% | -16.2% |
| Q4 2021 | $4,847,000 | -46.0% | 1,077,080 | 0.0% | 0.12% | -45.1% |
| Q3 2021 | $8,983,000 | – | 1,077,080 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DC Funds, LP | 630,000 | $1,612,800 | 33.20% |
| Lynx1 Capital Management LP | 5,224,600 | $13,374,976 | 8.85% |
| EcoR1 Capital, LLC | 5,000,000 | $12,800,000 | 0.43% |
| Deer Management Co. LLC | 1,245,505 | $3,188,493 | 0.39% |
| Simplify Asset Management Inc. | 1,046,916 | $2,680,105 | 0.31% |
| BVF INC/IL | 2,989,474 | $7,653,053 | 0.21% |
| Alphabet Inc. | 1,077,080 | $2,757,324 | 0.18% |
| DC Investments Management, LLC | 35,563 | $91,041 | 0.11% |
| Baker Brothers Advisors | 2,784,792 | $7,129,068 | 0.04% |
| Privium Fund Management (UK) Ltd | 15,825 | $41,462 | 0.03% |